Welcome to Belrose Pharma official website
Contact : 609.917.3013



Belrose Pharma Inc. is a privately-held clinical-stage biopharmaceutical company focused on the development of new treatments for orphan diseases and other conditions with high unmet medical needs.

Belrose is deploying its proprietary “releasable linker” conjugation technology and other techniques to improve the clinical efficacy of both novel therapeutics and approved molecules that would benefit from improved PK profile, increased bioavailability and more convenient administration.

In addition to its undisclosed portfolio of clinical candidates, Belrose is also developing several other Preclinical Development Candidates involving small molecules, peptides, and biologic drug candidates, including programs involving a combination of drugs using our proprietary linker technologies. These drug candidates, including programs in enzyme replacement therapies, diabetes, and oncology, are designed to improve the pharmacokinetics, pharmacodynamics, half-life, bioavailability, or tissue targeting of the original native drugs, and thus improve the overall benefits and use of a drug to patients.